HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 216-224

  Gharu, Lavina ^a   Ringe, Rajesh ^a   Bhattacharya, Jayanta ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

CCR5; CD4; CD4+ T cells; Clade C; Coreceptor; HIV 1; T20; TAK 779

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; ENFUVIRTIDE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CLADISTICS; CONFORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INDIAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS RESISTANCE;

AMIDES; ANTI-HIV AGENTS; ANTIGENS, CD4; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN BINDING; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, CCR5; RECEPTORS, HIV; SEQUENCE ANALYSIS, DNA; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79956295818     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.04.003     Document Type: Article

References (47)

1. Berger E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 1997, 11(Suppl. A):S3-16.
2. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657-700.
3. Bhattacharya J., Peters P.J., Clapham P.R. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. AIDS 2003, 17(Suppl. 4):S35-43.
4. Blaak H., van't Wout A.B., Brouwer M., Hooibrink B., Hovenkamp E., Schuitemaker H. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(3):1269-1274.
5. Cecilia D., Kulkarni S.S., Tripathy S.P., Gangakhedkar R.R., Paranjape R.S., Gadkari D.A. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000, 271(2):253-258.
6. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 1992, 66(11):6547-6554.
7. Cilliers T., Nhlapo J., Coetzer M., Orlovic D., Ketas T., Olson W.C., Moore J.P., Trkola A., Morris L. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 2003, 77(7):4449-4456.
8. Clapham P.R., McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 2002, 83(Pt 8):1809-1829.
9. Coetzer M., Cilliers T., Papathanasopoulos M., Ramjee G., Karim S.A., Williamson C., Morris L. Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS Res. Hum. Retroviruses 2007, 23(2):316-321.
10. de Roda Husman A.M., van Rij R.P., Blaak H., Broersen S., Schuitemaker H. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression. J. Infect. Dis. 1999, 180(4):1106-1115.
11. Dehghani H., Puffer B.A., Doms R.W., Hirsch V.M. Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5. J. Virol. 2003, 77(11):6405-6418.
12. Dejucq N., Simmons G., Clapham P.R. Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5. J. Virol. 1999, 73(9):7842-7847.
13. Dubey S., Khalid M., Wesley C., Khan S.A., Wanchu A., Jameel S. Downregulation of CCR5 on activated CD4T cells in HIV-infected Indians. J. Clin. Virol. 2008, 43(1):25-31.
14. Gharu L., Ringe R., Pandey S., Paranjape R., Bhattacharya J. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop. Virus Res. 2009, 144(1-2):306-314.
15. Gharu L., Ringe R., Satyakumar A., Patil A., Bhattacharya J. Evidence of HIV Type 1 Clade C env clones containing Low V3 loop charge obtained from an AIDS patient in India that uses CXCR6 and CCR8 for entry in addition to CCR5. AIDS Res. Hum. Retroviruses 2011, 27(2):211-219.
16. Glushakova S., Yi Y., Grivel J.C., Singh A., Schols D., De Clercq E., Collman R.G., Margolis L. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Invest. 1999, 104(5):R7-R11.
17. Gorry P.R., Taylor J., Holm G.H., Mehle A., Morgan T., Cayabyab M., Farzan M., Wang H., Bell J.E., Kunstman K., Moore J.P., Wolinsky S.M., Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J. Virol. 2002, 76(12):6277-6292.
18. Isaacman-Beck J., Hermann E.A., Yi Y., Ratcliffe S.J., Mulenga J., Allen S., Hunter E., Derdeyn C.A., Collman R.G. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 2009, 83(16):8208-8220.
19. Johnston E.R., Zijenah L.S., Mutetwa S., Kantor R., Kittinunvorakoon C., Katzenstein D.A. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J. Virol. 2003, 77(13):7682-7688.
20. Koyanagi Y., Miles S., Mitsuyasu R.T., Merrill J.E., Vinters H.V., Chen I.S. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987, 236(4803):819-822.
21. Kumarasamy N., Vallabhaneni S., Flanigan T.P., Mayer K.H., Solomon S. Clinical profile of HIV in India. Indian J. Med. Res. 2005, 121(4):377-394.
22. Lahuerta M., Aparicio E., Bardaji A., Marco S., Sacarlal J., Mandomando I., Alonso P., Martinez M.A., Menendez C., Naniche D. Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique. AIDS Res. Hum. Retroviruses 2008, 24(2):327-335.
23. Lakhashe S., Tripathy S., Paranjape R., Bhattacharya J. Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res. Hum. Retroviruses 2008, 24(1):92-99.
24. Li M., Gao F., Mascola J.R., Stamatatos L., Polonis V.R., Koutsoukos M., Voss G., Goepfert P., Gilbert P., Greene K.M., Bilska M., Kothe D.L., Salazar-Gonzalez J.F., Wei X., Decker J.M., Hahn B.H., Montefiori D.C. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 2005, 79(16):10108-10125.
25. Li S., Juarez J., Alali M., Dwyer D., Collman R., Cunningham A., Naif H.M. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 1999, 73(12):9741-9755.
26. Locati M., Murphy P.M. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 1999, 50:425-440.
27. Moore J.P., Parren P.W., Burton D.R. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J. Virol. 2001, 75:5721-5729.
28. Morris L., Cilliers T., Bredell H., Phoswa M., Martin D.J. CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res. Hum. Retroviruses 2001, 17(8):697-701.
29. Osmanov S., Pattou C., Schwardlander N.W.B., Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. 2002, 29:184-190.
30. Ostrowski M.A., Chun T.W., Justement S.J., Motola I., Spinelli M.A., Adelsberger J., Ehler L.A., Mizell S.B., Hallahan C.W., Fauci A.S. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J. Virol. 1999, 73(8):6430-6435.
31. Peeters M. Recombinant HIV sequences: their role in the global epidemic. HIV Sequence Compendium 2000. Theoretical Biology and Biophysics Group 2000, 39-54. Los Alamos National Laboratory, Los Alamos, N. Mexico. F.B. Kuiken, C.B. Hahn, P. Marx, F. McCutchan, J. Mellors, J. Mullins, J. Sodroski, S. Wolinksy, B. Korber (Eds.).
32. Peeters M., Vincent R., Perret J.L., Lasky M., Patrel D., Liegeois F., Courgnaud V., Seng R., Matton T., Molinier S., Delaporte E. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999, 20(2):115-121.
33. Peters P.J., Bhattacharya J., Hibbitts S., Dittmar M.T., Simmons G., Bell J., Simmonds P., Clapham P.R. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J. Virol. 2004, 78(13):6915-6926.
34. Peters P.J., Duenas-Decamp M.J., Sullivan W.M., Brown R., Ankghuambom C., Luzuriaga K., Robinson J., Burton D.R., Bell J., Simmonds P., Ball J., Clapham P.R. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology 2008, 5:5.
35. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage tropic isolates of human immunodeficiency virus type 1. J. Virol. 1998, 72(4):2855-2864.
36. Puffer B.A., Pohlmann S., Edinger A.L., Carlin D., Sanchez M.D., Reitter J., Watry D.D., Fox H.S., Desrosiers R.C., Doms R.W. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J. Virol. 2002, 76(6):2595-2605.
37. Reeves J.D., Gallo S.A., Ahmad N., Miamidian J.L., Harvey P.E., Sharron M., Pohlmann S., Sfakianos J.N., Derdeyn C.A., Blumenthal R., Hunter E., Doms R.W. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(25):16249-16254.
38. Reeves J.D., Miamidian J.L., Biscone M.J., Lee F.H., Ahmad N., Pierson T.C., Doms R.W. Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity. J. Virol. 2004, 78(10):5476-5485.
39. Ringe R., Thakar M., Bhattacharya J. Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naive Indian patients with recent infection. Retrovirology 2010, 7(1):76.
40. Ryzhova E., Whitbeck J.C., Canziani G., Westmoreland S.V., Cohen G.H., Eisenberg R.J., Lackner A., Gonzalez-Scarano F. Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4. J. Virol. 2002, 76(15):7903-7909.
41. Schuitemaker H., Kootstra N.A., de Goede R.E., de Wolf F., Miedema F., Tersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 1991, 65(1):356-363.
42. Shankarappa R., Chatterjee R., Learn G.H., Neogi D., Ding M., Roy P., Ghosh A., Kingsley L., Harrison L., Mullins J.I., Gupta P. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 2001, 75(75):10479-10487.
43. Simmons G., Wilkinson D., Reeves J.D., Dittmar M.T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P.W., Weiss R.A., Clapham P.R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 1996, 70:8355-8360.
44. Vajpayee M., Kaushik S., Sreenivas V., Mojumdar K., Mendiratta S., Chauhan N.K. Role of immune activation in CD4+ T-cell depletion in HIV-1 infected Indian patients. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28(1):69-73.
45. Valentin A., Albert J., Fenyo E.M., Asjo B. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 1994, 68(10):6684-6689.
46. Wadhwa A., Kaur R., Agarwal S.K., Jain S., Bhalla P. AIDS-related opportunistic mycoses seen in a tertiary care hospital in North India. J. Med. Microbiol. 2007, 56(Pt 8):1101-1106.
47. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46(6):1896-1905.